FDA Import Refusal 1FX-4500417-4/50003/1 — SAMRVIR BIOTECH PVT LTD
The FDA refused shipment 1FX-4500417-4/50003/1 from SAMRVIR BIOTECH PVT LTD (India) on Sep 24, 2026. The refused product falls under Drugs and Biologics — GLIMEPIRIDE (ANTI-DIABETIC). Cited charges: 118,75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Sep 24, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA31 GLIMEPIRIDE (ANTI-DIABETIC)
- Charges
- 118,75